Oligonucleotides are exploding as a therapeutic modality. The ability of oligonucleotide therapies to modulate disease mechanisms at the messenger RNA (mRNA) level opens up the potential to treat pathologies previously considered “undruggable.”
The molecular properties of oligonucleotides place them somewhere between small molecules and protein therapeutics. SCIEX recognizes the special analytical challenges that oligonucleotide therapeutics present to scientists. We have partnered with scientists in the pharmaceutical and biopharmaceutical industries to develop precise, sensitive and efficient analytical solutions to help enable your investigational new drug (IND) or new drug application (NDA) programs.
Many existing oligonucleotide assays can be too rigid to adapt when problems arise. Explore flexible and compliant data analysis options that give you complete information from a single injection.
Understanding oligonucleotides from every angle: utilizing mass spectrometry for characterization and quantification
Discover a solution that provides extreme negative ion mode sensitivity and detection. Benefit from fewer required experiments, faster candidate selection and shorter development time.
Improve sensitivity for antisense oligonucleotide quantification in plasma using microLC-MRM methodology
Sensitive quantification of therapeutic oligonucleotides extracted from plasma
Approaches for quantification of oligonucleotides in extracted plasma using high resolution mass spectrometry
Full length and truncated oligonucleotides with ligand binding assay formats are difficult to distinguish. With high resolution MS and MS/MS solutions, you can confirm the mass of full length and clipped or truncated oligonucleotides with confidence.
Analysis of locked nucleic acid (LNA) oligonucleotides (ON) and related impurities using accurate mass spectrometry
The market-leading negative ion performance across our mass spectrometry portfolio delivers extreme sensitivity for your most challenging therapeutic oligonucleotides. You will see not only a boost in sensitivity with microflow chromatography, but also a decrease in system contamination and downtime for cleaning. Confidently run your analyses with the ease of connecting SCIEX sources and employing instrumentation designed specifically for microflow.
Great negative ion mode performance with the ability to simultaneously quantify both analytes and metabolites.
Excellent negative ion mode performance ensures high sensitivity for the lowest levels of oligonucleotide qualification.
Experience the intelligent union of high sensitivity, ease of use and robustness to quantify oligonucleotides.
This compliant-ready solution is optimized for qualitative and quantitative data analysis.
Automatically deconvolute multiply-charged ESI/LC/MS mass spectra from a wide variety of biomolecules.
As the technologies for manufacturing and analysis of gene therapy products continue to evolve, it’s important to keep up with industry trends and analytical advancements. This compendium can help you advance your gene therapies and oligonucleotide therapeutics to the next level with the latest tools and methods.
Whether you need high sensitivity for quantification or to characterize impurities and catabolites, SCIEX has complete end-to-end solutions for fast, easy and confident LC-MS oligonucleotide analysis.